PepPool: TB (ESAT-6), scanning

3624-1

Publications: 0

Documents

Questions?

Validated for our assays.

Content

Peptide pool with 21 peptides, 25 ug of each peptide. Supplied in one vial (lyophilized).

In stock

Delivery 4-9 business days

Shipping $0

Product specifications

Intended use

This peptide pool is intended for studying immune responses against TB (ESAT-6) using immunoassays such as ELISpot and FluoroSpot. It induces cytokine secretion from antigen-specific human T cells. For research use only. Not for use in diagnostic procedures.

Serum/Plasma samples

Description
The TB (ESAT-6) scanning pool induces secretion of e.g., IFN-γ from human T cells. It contains 21 peptides from the Mycobacterium tuberculosis early secretory antigenic target 6 kDa (ESAT-6) protein. The peptides are 15-mers overlapping with 11 amino acids, covering the complete protein. The mean purity of the synthetic peptides is 98%.

Peptides included in the peptide pool are listed in the datasheet.

Recommendation

Product details

Product	PepPool: TB (ESAT-6), scanning
Application	T cell stimulation, ELISpot, FluoroSpot
Reactivity	Human
Supplied in	Lyophilized
Contents	Peptide pool with 21 peptides, 25 ug of each peptide. Supplied in one vial (lyophilized).

Shipping and Storage

Shipping	Shipped at ambient temperature.
Storage	Store at -20 °C or below upon receipt.

Performance

PBMC (250,000 cells/well) from a patient with tuberculosis infection were incubated overnight in the absence or presence of the ESAT-6 scanning pool and the number of cells secreting IFN-γ was analyzed by ELISpot.

Documents

Datasheet/Protocol
SDS

Product highlights

Highlighted research, Published December 21, 2023

Tuberculosis diagnosis with spots

Early and precise diagnosis is crucial for effective TB management, and ELISpot is increasingly being used for this purpose. This white paper examines the advantages of ELISpot in TB diagnosis and suggests future antigens and biomarkers that can enhance diagnostic accuracy.

Behind the scenes, Published November 17, 2023

Webinar: Novel insights into TB vaccines and diagnostics

Recording now available!

Publications (0)

Loading publications...